JAXICLAR Trademark

Trademark Overview


On Wednesday, March 11, 2009, a trademark application was filed for JAXICLAR with the United States Patent and Trademark Office. The USPTO has given the JAXICLAR trademark a serial number of 77688129. The federal status of this trademark filing is ABANDONED - EXPRESS AFTER PUB as of Wednesday, October 28, 2009. This trademark is owned by Pfizer Inc.. The JAXICLAR trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of hormonal disorders and the prevention of osteoporosis; Pharmaceutical preparations for the treatment of cardiovascular, central nervous system, endocrine, gastrointestinal, gynecological, hematologic, immunological, infectious, inflammatory, menopausal, metabolic, musculoskeletal, neurological, oncological, ophthalmological, psychiatric, respiratory, sleep, urogenital, urological and viral diseases and disorders; pharmaceutical preparations for the treatment of allergies, erectile dysfunction, sexual dysfunction, obesity, pain, and HIV/AIDS; pharmaceutical preparations, namely, antifungal preparations, dermatological preparations, smoking cessation preparations; vaccines for human use; adjuvants for use with human vaccines
jaxiclar

General Information


Serial Number77688129
Word MarkJAXICLAR
Filing DateWednesday, March 11, 2009
Status605 - ABANDONED - EXPRESS AFTER PUB
Status DateWednesday, October 28, 2009
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, July 14, 2009

Trademark Statements


Goods and ServicesPharmaceutical preparations for the treatment of hormonal disorders and the prevention of osteoporosis; Pharmaceutical preparations for the treatment of cardiovascular, central nervous system, endocrine, gastrointestinal, gynecological, hematologic, immunological, infectious, inflammatory, menopausal, metabolic, musculoskeletal, neurological, oncological, ophthalmological, psychiatric, respiratory, sleep, urogenital, urological and viral diseases and disorders; pharmaceutical preparations for the treatment of allergies, erectile dysfunction, sexual dysfunction, obesity, pain, and HIV/AIDS; pharmaceutical preparations, namely, antifungal preparations, dermatological preparations, smoking cessation preparations; vaccines for human use; adjuvants for use with human vaccines

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code8 - Abandoned
Class Status DateWednesday, October 28, 2009
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NamePfizer Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressNew York, NY 10017

Party NamePfizer Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNew York, NY 10017

Trademark Events


Event DateEvent Description
Wednesday, October 28, 2009ABANDONMENT NOTICE MAILED - AFTER PUBLICATION
Wednesday, October 28, 2009ABANDONMENT - AFTER PUBLICATION
Wednesday, October 28, 2009TEAS EXPRESS ABANDONMENT RECEIVED
Tuesday, October 6, 2009NOA MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, July 14, 2009PUBLISHED FOR OPPOSITION
Wednesday, June 24, 2009NOTICE OF PUBLICATION
Friday, June 5, 2009LAW OFFICE PUBLICATION REVIEW COMPLETED
Friday, June 5, 2009ASSIGNED TO LIE
Wednesday, June 3, 2009APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, June 3, 2009ASSIGNED TO EXAMINER
Monday, March 16, 2009NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Saturday, March 14, 2009NEW APPLICATION ENTERED IN TRAM